1,533
Views
4
CrossRef citations to date
0
Altmetric
Gastroenterology

Monitoring established Crohn’s disease with pan-intestinal video capsule endoscopy in Europe: clinician consultation using the nominal group technique

, , , , , , , & show all
Pages 1547-1554 | Received 08 Apr 2021, Accepted 07 Jun 2021, Published online: 30 Jun 2021

References

  • Burisch J, Pedersen N, Čuković-Čavka S, et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut. 2014;63(4):588–597.
  • Dubcenco E, Jeejeebhoy KN, Petroniene R, et al. Capsule endoscopy findings in patients with established and suspected small-bowel Crohn’s disease: correlation with radiologic, endoscopic, and histologic findings. Gastrointest Endosc. 2005;62(4):538–544.
  • Cosnes J, Gower–Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785–1794.e4.
  • Burisch J, Jess T, Martinato M, et al. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013;7(4):322–337.
  • Lewis RT, Maron DJ. Efficacy and complications of surgery for Crohn’s disease. Gastroenterol Hepatol. 2010;6(9):587–596. http://www.ncbi.nlm.nih.gov/pubmed/21088749. Accessed December 20, 2018.
  • Chang S, Malter L, Hudesman D. Disease monitoring in inflammatory bowel disease. World J Gastroenterol. 2015;21(40):11246–11259.
  • Gomollón F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s Disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11(1):3–25.
  • Sauter B, Beglinger C, Girardin M, et al. Monitoring disease activity and progression in Crohn’s disease: a Swiss perspective on the IBD ahead ‘optimised monitoring’ recommendations. Digestion. 2014;89(4):299–309.
  • Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427–434.
  • Papay P, Ignjatovic A, Karmiris K, et al. Optimising monitoring in the management of Crohn’s disease: a physician’s perspective. J Crohns Colitis. 2013;7(8):653–669.
  • Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144–164.
  • Orlando A, Guglielmi FW, Cottone M, et al. Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease. Dig Liver Dis. 2013;45(12):986–991.
  • Pennazio M, Spada C, Eliakim R, et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2015;47(4):352–386.
  • Ooi CJ, Makharia GK, Hilmi I, et al. Asia pacific consensus statements on Crohn’s disease. Part 1: definition, diagnosis, and epidemiology: (Asia Pacific Crohn’s Disease Consensus-Part 1). J Gastroenterol Hepatol. 2016;31(1):45–55.
  • Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110(9):1324–1338.
  • Reinink AR, Lee TC, Higgins PDR. Endoscopic mucosal healing predicts favorable clinical outcomes in inflammatory bowel disease: a meta-analysis. Inflamm Bowel Dis. 2016;22(8):1859–1869.
  • Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7(12):982–1018.
  • Kopylov U, Yablecovitch D, Lahat A, et al. Detection of small bowel mucosal healing and deep remission in patients with known small Bowel Crohn’s Disease using biomarkers, capsule endoscopy and imaging. Am J Gastroenterol. 2015;110(9):1316–1323.
  • Sandborn WJ. The future of inflammatory bowel disease therapy: where do we go from here? Dig Dis. 2012;30(s3):140–144.
  • Colombel J-F, Panaccione R, Bossuyt P, et al. Effect of tight control management on Crohn’s disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet. 2017;390(10114):2779–2789.
  • Kopylov U, Rosenfeld G, Bressler B, et al. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(4):742–756.
  • Burri E, Beglinger C, Lehmann FS. Monitoring of therapy for inflammatory Bowel Disease. Digestion. 2012;86(s1):1–5.
  • Laharie D, Mesli S, El Hajbi F, et al. Prediction of Crohn’s disease relapse with faecal calprotectin in infliximab responders: a prospective study. Aliment Pharmacol Ther. 2011;34(4):462–469.
  • Koulaouzidis A, Douglas S, Rogers MA, et al. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy. Scand J Gastroenterol. 2011;46(5):561–566.
  • Costa F, Mumolo MG, Ceccarelli L, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease. Gut. 2005;54(3):364–368.
  • Costa F, Mumolo MG, Bellini M, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis. 2003;35(9):642–647. http://www.ncbi.nlm.nih.gov/pubmed/14563186. Accessed December 20, 2018.
  • Park S-K, Ye BD, Kim KO, et al. Guidelines for video capsule endoscopy: emphasis on Crohn’s disease. Clin Endosc. 2015;48(2):128–135.
  • Lorenzo-Zúñiga V, de Vega VM, Domènech E, et al. Impact of capsule endoscopy findings in the management of Crohn’s Disease. Dig Dis Sci. 2010;55(2):411–414.
  • Oliva S, Aloi M, Viola F, et al. A treat to target strategy using panenteric capsule endoscopy in pediatric patients with Crohn’s Disease. Clin Gastroenterol Hepatol. 2019;17(10):2060–2067.e1.
  • Negreanu L, Smarandache G, Mateescu RB. Role of capsule endoscopy Pillcam COLON 2 in patients with known or suspected Crohn's disease who refused colonoscopy or underwent incomplete colonoscopic exam: a case series. Tech Coloproctol. 2014;18(3):277–283.
  • Le Berre C, Trang-Poisson C, Bourreille A. Small bowel capsule endoscopy and treat-to-target in Crohn’s disease: a systematic review. World J Gastroenterol. 2019;25(31):4534–4554.
  • Delbecq AL, Van de Ven AH. A group process model for problem identification and program planning. J Appl Behav Sci. 1971;7(4):466–492.
  • McMillan SS, King M, Tully MP. How to use the nominal group and Delphi techniques. Int J Clin Pharm. 2016;38(3):655–662.
  • Cantrill JA, Sibbald B, Buetow S. The Delphi and nominal group techniques in health services research. Int J Pharm Pract. 2011;4(2):67–74.
  • Harvey N, Holmes CA. Nominal group technique: an effective method for obtaining group consensus. Int J Nurs Pract. 2012;18(2):188–194.
  • Sanderson T, Hewlett S, Richards P, et al. Utilizing qualitative data from nominal groups: exploring the influences on treatment outcome prioritization with rheumatoid arthritis patients. J Health Psychol. 2012;17(1):132–142.
  • Miller D, Shewchuk R, Elliot TR, et al. Nominal group technique: a process for identifying diabetes self-care issues among patients and caregivers. Diabetes Educ. 2000;26(2):305–314.
  • Dewar A, White M, Posade ST, et al. Using nominal group technique to assess chronic pain, patients’ perceived challenges and needs in a community health region. Health Expect. 2003;6(1):44–52. http://www.ncbi.nlm.nih.gov/pubmed/12603627.
  • Drennan V, Walters K, Lenihan P, et al. Priorities in identifying unmet need in older people attending general practice: a nominal group technique study. Fam Pract. 2007;24(5):454–460.
  • Vella K, Goldfrad C, Rowan K, et al. Use of consensus development to establish national research priorities in critical care. BMJ. 2000;320(7240):976–980. http://www.ncbi.nlm.nih.gov/pubmed/10753149. Accessed December 4, 2018.
  • Dionisio PM, Gurudu SR, Leighton JA, et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel crohn’s disease: a meta-analysis. Am J Gastroenterol. 2010;105(6):1240–1248.
  • Amitai MM, Ben-Horin S, Eliakim R, et al. Magnetic resonance enterography in Crohn’s disease: a guide to common imaging manifestations for the IBD physician. J Crohns Colitis. 2013;7(8):603–615.
  • Rozendorn N, Amitai MM, Eliakim RA, et al. A review of magnetic resonance enterography-based indices for quantification of Crohn’s disease inflammation. Therap Adv Gastroenterol. 2018;11:1756284818765956.
  • Ordás I, Rimola J, Alfaro I, et al. Development and validation of a simplified magnetic resonance index of activity for Crohn’s. Disease. Gastroenterology. 2019;157(2):432–439.e1.
  • Oliva S, Cucchiara S, Civitelli F, et al. Colon capsule endoscopy compared with other modalities in the evaluation of pediatric Crohn's disease of the small bowel and colon. Gastrointest Endosc. 2016;83(5):975–983.
  • Saunders R, Torres RT, Konsinski L. Evaluating the clinical and economic consequences of using video capsule endoscopy to monitor Crohn’s disease. Clin Exp Gastroenterol. 2019;12:375–384.
  • Lobo A, Torrejon Torres R, McAlindon M, et al. Economic analysis of the adoption of capsule endoscopy within the British NHS. Int J Qual Health Care. 2020;32(5):332–341.
  • Kim SH, Yang DH, Kim JS. Current status of interpretation of small bowel capsule endoscopy. Clin Endosc. 2018;51(4):329–333.
  • Le Berre C, Sandborn WJ, Aridhi S, et al. Application of artificial intelligence to gastroenterology and hepatology. Gastroenterology. 2020;158(1):76–94.e2.
  • Hassan C, Wallace MB, Sharma P, et al. New artificial intelligence system: first validation study versus experienced endoscopists for colorectal polyp detection. Gut. 2020;69(5):799–800.
  • Klang E, Barash Y, Margalit RY, et al. Deep learning algorithms for automated detection of Crohn's disease ulcers by video capsule endoscopy. Gastrointest Endosc. 2020;91(3):606–613.e2.
  • Rex DK, Adler SN, Aisenberg J, et al. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology. 2015;148(5):948–957.e2.
  • Pasha SF, Pennazio M, Rondonotti E, et al. Capsule retention in Crohn’s Disease: a meta-analysis. Inflamm Bowel Dis. 2020;26(1):33–42.